During the past decade, Sisters of Charity Providence Hospitals conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sisters of Charity Providence Hospitals" are "Coronary Artery Disease" (3 trials), "Acute Myocardial Infarction" (1 trials), "Coronary Disease" (1 trials) and "Coronary Restenosis" (1 trials). Many other conditions were trialed in "Sisters of Charity Providence Hospitals" in a lesser frequency.

Most popular intervention types in "Sisters of Charity Providence Hospitals" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PROMUS Element Plus" (1 trials), "Pexelizumab" (1 trials), "Placebo infusion" (1 trials), "SYNERGY" (1 trials) and "TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sisters of Charity Providence Hospitals" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sisters of Charity Providence Hospitals". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Sisters of Charity Providence Hospitals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sisters of Charity Providence Hospitals, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".